258 related articles for article (PubMed ID: 24623168)
1. Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.
Opitz I; Bueno R; Lim E; Pass H; Pastorino U; Boeri M; Rocco G;
Eur J Cardiothorac Surg; 2014 Oct; 46(4):602-6. PubMed ID: 24623168
[TBL] [Abstract][Full Text] [Related]
2. Surgical Management of Malignant Pleural Mesothelioma: An Update of Clinical Evidence.
Cao C; Akhunji Z; Fu B; Wilcox C; Novis E; Tian DH; Yan TD
Semin Thorac Cardiovasc Surg; 2015; 27(1):6-8. PubMed ID: 26074102
[TBL] [Abstract][Full Text] [Related]
3. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
[TBL] [Abstract][Full Text] [Related]
4. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
Barbieri PG
Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
[No Abstract] [Full Text] [Related]
5. Iterative surgery for recurrent malignant pleural mesothelioma in long-term survivor.
Leuzzi G; Melis E; Forcella D; Facciolo F
ANZ J Surg; 2017 Nov; 87(11):946-947. PubMed ID: 25879924
[No Abstract] [Full Text] [Related]
6. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
[TBL] [Abstract][Full Text] [Related]
7. Making the case for molecular staging of malignant pleural mesothelioma.
Bueno R
Semin Thorac Cardiovasc Surg; 2009; 21(2):188-93. PubMed ID: 19822292
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
9. Non-asbestos-related malignant pleural mesothelioma.
Kanbay A; Ozer Simsek Z; Tutar N; Yılmaz I; Buyukoglan H; Canoz O; Demir R
Intern Med; 2014; 53(17):1977-9. PubMed ID: 25175133
[TBL] [Abstract][Full Text] [Related]
10. The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence.
Bertoglio P; Waller DA
Expert Rev Respir Med; 2016 Jun; 10(6):663-72. PubMed ID: 27015594
[TBL] [Abstract][Full Text] [Related]
11. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
[TBL] [Abstract][Full Text] [Related]
12. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
[TBL] [Abstract][Full Text] [Related]
14. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
Pira E; Boffetta P; Ciocan C
Tumori; 2019 Aug; 105(4):359-360. PubMed ID: 31418338
[No Abstract] [Full Text] [Related]
15. Prognostic factors in malignant pleural mesothelioma.
Davidson B
Hum Pathol; 2015 Jun; 46(6):789-804. PubMed ID: 25824607
[TBL] [Abstract][Full Text] [Related]
16. European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
Opitz I; Bille A; Dafni U; Nackaerts K; Ampollini L; de Perrot M; Brcic L; Nadal E; Syrigos K; Gray SG; Aerts J; Curioni-Fontecedro A; Rüschoff JH; Monkhorst K; Weynand B; Silini EM; Bavaghar-Zaeimi F; Jakopovic M; Llatjos R; Tsimpoukis S; Finn SP; von der Thüsen J; Marti N; Dimopoulou G; Kammler R; Peters S; Stahel RA; Falcoz PE; Brunelli A; Baas P;
J Thorac Oncol; 2023 Sep; 18(9):1233-1247. PubMed ID: 37356802
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease.
Galetta D; Catino A; Misino A; Logroscino A; Fico M
Tumori; 2016; 102(2):127-30. PubMed ID: 26108245
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma.
Hamasaki M; Kinoshita Y; Yoshimura M; Matsumoto S; Kamei T; Hiroshima K; Sato A; Tsujimura T; Kawahara K; Nabeshima K
Histopathology; 2019 Jul; 75(1):153-155. PubMed ID: 30957899
[No Abstract] [Full Text] [Related]
19. [The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].
Jassem J; Biernat W; Bryl M; Chorostowska-Wynimko J; Dziadziuszko R; Krawczyk P; Kordek R; Kowalski DM; Krzakowski M; Olszewski W; Orłowski T; Ramlau R; Rzyman W
Pneumonol Alergol Pol; 2014; 82(2):133-49. PubMed ID: 24615197
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review.
Sheff KW; Hoda MA; Dome B; Hegedus B; Klepetko W; Weiss GJ
Microrna; 2012; 1(1):40-8. PubMed ID: 25048089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]